Document is current
Any future updates will be listed below
-
Authors
Sim-Devadas, Ai Ling
Soon, Sherry Bee Siang
Lakshmanan, Ellil Mathiyan
Jain, Ritu
Chotirmall, Sanjay H.
Manski-Nankervis, Jo-Anne
- License Information
-
More Information
Article History
Received: 27 June 2025
Accepted: 11 September 2025
First Online: 27 October 2025
Declarations
:
: Not applicable. This is a commentary article which describes the development of OPEN. It was not conducted as a research project.
: ASD and JMN are executive and academic leads of OPEN. SHC reports consultancy fees from CSL Behring, Boehringer Ingelheim, Sanofi, GSK, Zaccha Pte. Ltd. and Pneumagen Ltd; lecture fees from AstraZeneca, CSL Behring, Boehringer Ingelheim and Chiesi Farmaceutici; and participation in data safety monitoring boards (DSMBs) for Inovio Pharmaceuticals Inc. and Imam Abdulrahman Bin Faisal University. RJ reports lecture fees from Chiesi Farmaceutici.
